Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non-Current Liabilities: 2022-2024

Historic Other Non-Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2024 value amounting to $40,000.

  • Orchestra BioMed Holdings' Other Non-Current Liabilities was N/A to $248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $248,000, marking a year-over-year change of. This contributed to the annual value of $40,000 for FY2024, which is N/A change from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Other Non-Current Liabilities stood at $40,000 for FY2024, which was down 98.09% from $2.1 million recorded in FY2022.
  • Orchestra BioMed Holdings' Other Non-Current Liabilities' 5-year high stood at $2.1 million during FY2022, with a 5-year trough of $40,000 in FY2024.
  • Moreover, its 2-year median value for Other Non-Current Liabilities was $1.1 million (2022), whereas its average is $1.1 million.